Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201446656> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W3201446656 endingPage "1022" @default.
- W3201446656 startingPage "1022" @default.
- W3201446656 abstract "Since marketing authorization, cases of neuralgic amyotrophy (NA), facial paralysis/Bell’s palsy (FP/BP), and Guillain-Barré syndrome (GBS) were reported with COVID-19 vaccines of different technologies. This study aimed to assess whether NA, FP/BP, and GBS were more frequently reported in VigiBase with COVID-19 vaccines (of any technologies) than with other viral vaccines, over the full database and across potential risk groups by sex and age. The reporting odds ratio (ROR) with 95% confidence interval (95% CI) was used as the measure of disproportionality and subgroup disproportionality analyses were performed by sex and age. Out of 808,906 safety reports with COVID-19 vaccines, 57 (0.01%) reported NA, 3320 (0.4%) FP/BP, and 632 (0.1%) GBS. There were not signals of disproportionate reporting for NA and GBS with COVID-19 vaccines against other viral vaccines. FP/BP was disproportionately more frequently reported with COVID-19 vaccines than with other viral vaccines over the full database (ROR 1.12, 95%CI 1.07–1.17), in males (ROR 1.65, 95%CI 1.54–1.78) and in age subgroups 65–74 years (ROR 1.21, 95%CI 1.05–1.39) and ≥75 years (ROR 1.84, 95%CI 1.52–2.22). Albeit not proving causation, these findings might support clinicians in decision-making for patients potentially at risk for developing an acute inflammatory neuropathy with COVID-19 vaccines." @default.
- W3201446656 created "2021-09-27" @default.
- W3201446656 creator A5006817285 @default.
- W3201446656 creator A5030631016 @default.
- W3201446656 creator A5068196086 @default.
- W3201446656 creator A5083393995 @default.
- W3201446656 creator A5090072434 @default.
- W3201446656 date "2021-09-14" @default.
- W3201446656 modified "2023-10-06" @default.
- W3201446656 title "Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase" @default.
- W3201446656 cites W2190082151 @default.
- W3201446656 cites W2223304763 @default.
- W3201446656 cites W2335127767 @default.
- W3201446656 cites W2407540121 @default.
- W3201446656 cites W3036015309 @default.
- W3201446656 cites W3130700303 @default.
- W3201446656 cites W3131650037 @default.
- W3201446656 cites W3132581533 @default.
- W3201446656 cites W3152941353 @default.
- W3201446656 cites W3156168605 @default.
- W3201446656 cites W3156934133 @default.
- W3201446656 cites W3159001141 @default.
- W3201446656 cites W3160295904 @default.
- W3201446656 cites W3164938519 @default.
- W3201446656 cites W3172281322 @default.
- W3201446656 cites W3175218588 @default.
- W3201446656 doi "https://doi.org/10.3390/vaccines9091022" @default.
- W3201446656 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8473382" @default.
- W3201446656 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34579259" @default.
- W3201446656 hasPublicationYear "2021" @default.
- W3201446656 type Work @default.
- W3201446656 sameAs 3201446656 @default.
- W3201446656 citedByCount "16" @default.
- W3201446656 countsByYear W32014466562022 @default.
- W3201446656 countsByYear W32014466562023 @default.
- W3201446656 crossrefType "journal-article" @default.
- W3201446656 hasAuthorship W3201446656A5006817285 @default.
- W3201446656 hasAuthorship W3201446656A5030631016 @default.
- W3201446656 hasAuthorship W3201446656A5068196086 @default.
- W3201446656 hasAuthorship W3201446656A5083393995 @default.
- W3201446656 hasAuthorship W3201446656A5090072434 @default.
- W3201446656 hasBestOaLocation W32014466561 @default.
- W3201446656 hasConcept C126322002 @default.
- W3201446656 hasConcept C156957248 @default.
- W3201446656 hasConcept C187212893 @default.
- W3201446656 hasConcept C187960798 @default.
- W3201446656 hasConcept C203014093 @default.
- W3201446656 hasConcept C2778691916 @default.
- W3201446656 hasConcept C2779134260 @default.
- W3201446656 hasConcept C3008058167 @default.
- W3201446656 hasConcept C44249647 @default.
- W3201446656 hasConcept C524204448 @default.
- W3201446656 hasConcept C71924100 @default.
- W3201446656 hasConceptScore W3201446656C126322002 @default.
- W3201446656 hasConceptScore W3201446656C156957248 @default.
- W3201446656 hasConceptScore W3201446656C187212893 @default.
- W3201446656 hasConceptScore W3201446656C187960798 @default.
- W3201446656 hasConceptScore W3201446656C203014093 @default.
- W3201446656 hasConceptScore W3201446656C2778691916 @default.
- W3201446656 hasConceptScore W3201446656C2779134260 @default.
- W3201446656 hasConceptScore W3201446656C3008058167 @default.
- W3201446656 hasConceptScore W3201446656C44249647 @default.
- W3201446656 hasConceptScore W3201446656C524204448 @default.
- W3201446656 hasConceptScore W3201446656C71924100 @default.
- W3201446656 hasIssue "9" @default.
- W3201446656 hasLocation W32014466561 @default.
- W3201446656 hasLocation W32014466562 @default.
- W3201446656 hasLocation W32014466563 @default.
- W3201446656 hasLocation W32014466564 @default.
- W3201446656 hasLocation W32014466565 @default.
- W3201446656 hasOpenAccess W3201446656 @default.
- W3201446656 hasPrimaryLocation W32014466561 @default.
- W3201446656 hasRelatedWork W2103590513 @default.
- W3201446656 hasRelatedWork W2153559369 @default.
- W3201446656 hasRelatedWork W2286371484 @default.
- W3201446656 hasRelatedWork W2790570163 @default.
- W3201446656 hasRelatedWork W2962230309 @default.
- W3201446656 hasRelatedWork W3044745925 @default.
- W3201446656 hasRelatedWork W4291824836 @default.
- W3201446656 hasRelatedWork W4293189971 @default.
- W3201446656 hasRelatedWork W4311387398 @default.
- W3201446656 hasRelatedWork W2308166127 @default.
- W3201446656 hasVolume "9" @default.
- W3201446656 isParatext "false" @default.
- W3201446656 isRetracted "false" @default.
- W3201446656 magId "3201446656" @default.
- W3201446656 workType "article" @default.